NGENF - NervGen Pharma reports Q2 results August, 21 2020 08:34 AM NervGen Pharma Corp NervGen Pharma (OTCQX:NGENF): Q2 GAAP EPS of -$0.09.The net cash burn for Q2 2020 from operating activities was ~$1.4M.Cash balance of $3.5MPress ReleaseMore news on: NervGen Pharma Corp., Earnings news and commentary, Healthcare stocks news, ,